The European Commission has approved the Covid-19 vaccine from French-Austrian biotechnology Valnja following a statement issued by the European Medicines Agency on the eve of the green light, Valnja said on Friday. The Valnja inactivated vaccine was approved for use as a primary series for adults aged 18 to 50 years, the statement said.
VLA2001 is the first vaccine to be approved in Europe using traditional inactivated viral technology. Five other vaccines have already been approved in the European Union: Pfizer-BioNTech և Moderna messenger RNA vaccines, AstraZeneca շ վե և և և ra av ax Ast Ast ra:: ax ax ax: ax: ax::::::::::::: on the so-called protein subunit technology.
Doubts about order
VLA2001 is also the first vaccine against Covid to receive a standard type of authorization, rather than a conventional marketing authorization, as was the case with the previous five vaccines in the event of an epidemic emergency. Therefore, Valnja could theoretically start supplying the European Union, with which he signed a preliminary agreement at the end of 2021 for a 60 million dose by 2023.
However, there are doubts about maintaining this order, as in May the EU announced that it was considering ending it in a significant context of world production.
Last Friday, biotech called for more orders from European countries to comply with the agreement. Valnya serum has already been approved in the United Kingdom, the United Arab Emirates, and the Kingdom of Bahrain, the only country where it is currently sold.
Source: Le Figaro
I’m Liza Grey, an experienced news writer and author at the Buna Times. I specialize in writing about economic issues, with a focus on uncovering stories that have a positive impact on society. With over seven years of experience in the news industry, I am highly knowledgeable about current events and the ways in which they affect our daily lives.